Read, discover and understand progress, achievements and outcomes of cancer research, education and clinical care delivered by the VCCC, our alliance members, supporters and partners.
I was reminded of the extraordinary workforce that exists across the alliance when visiting our partner organisations to share the VCCC Strategic Research Plan (SRP) this month.
A new targeted treatment option for patients with Chronic Lymphocytic Leukaemia (CLL) will be available from 1 March 2019 through the Australian Pharmaceutical Benefits Scheme (PBS).
Minister for Industry, Science and Technology of The Liberal National Government is providing more than $22 million for important early stage research that will lead to new interventions, cures and treatments of major diseases.
A new specialist university Masters degree will upskill researchers and professionals working in the cancer field, and has been developed with the support of the Andrews Labor Government.
The Albury-Wodonga Regional Cancer Centre Trust Fund has launched annual scholarships of up to $10,000 for the centre's nursing staff to keep them up to date with research and best practise. [paywall]
When Maureen Chrul was diagnosed with inoperable stage-one lung cancer 10 years ago, she told her family she didn't have the patience or the ability to fight it.
Ms Chrul, who is now 76, had raised six children as a single mother after her husband died in an industrial accident in the 1970s, all while working many different roles in hospitals around the city.
Deaths rates from rectal cancer are predicted to increase almost 60 per cent in Australia by 2035, while many other countries are seeing death rates fall.
On the plus side, Australia's rates of colon cancer are expected to fall by around 50 per cent by 2035. Death rates for both colon and rectal cancer are expected to drop globally but the total number of deaths is expected to rise, due to population growth and ageing.
This week many of you will have celebrated the success of friends and colleagues who were awarded an Australia Day honour.
Dr Belinda Yeo and Professor Bruce Mann have been appointed joint VCCC Research & Education Leads – Breast Cancer.
Many smokers are wary of going to the doctor when they develop respiratory symptoms, because they’re worried about getting ticked off for being a smoker in the first place.
That’s especially problematic because catching lung cancer early is key.
So how can health bodies get those at risk to see a doc earlier?
Throughout her career, Professor Mei Krishnasamy has worked to improve the evidence base for cancer nursing care, particularly for people with rarer cancers.
Capitalising on digital health technology
Patients with cancer living in regional and rural Victoria will soon have access to clinical trials, on their doorstep.
I’m very pleased to wrap up the year with the news that the first cancer clinical trial implemented through the VCCC Teletrials Program has opened in Albury, Wodonga and Bendigo.
Imperative that the conference provides innovative content that reflects the breadth and depth of our partners and collaborators
The VCCC Research Conference provides a spotlight for Victorian cancer research discoveries, education achievements and clinical translation outcomes, as well as bringing together national and international experts.
Range of initiatives now underway
Increasing clinical trials harmonisation and enhancing capability across alliance partner trial sites are key initiatives to improve benefits to patients and access to cancer clinical trials.
Helping Cancer Researchers Pinpoint The Issue
The Australian Cancer Research Foundation (ACRF) Translational Proteomic Facility is the first in Australia with the capability for protein-based assays that will complement the use of genomics in targeting cancer therapies.
The VCCC alliance with the University of Melbourne is coordinating a new Master of Cancer Sciences
Course coordinator Dr David Kok, Radiation Oncologist, Peter MacCallum Cancer Centre shares his passion for the new educational program with researcher and potential student Helen Sehric.
Last week I attended the inaugural Advances in Cancer Drug Discovery and Development Symposium, jointly presented by Cancer Therapeutics CRC - (CTx), Merck Sharpe and Dohme MSD, and the Victorian Comprehensive Cancer Centre alliance.
Congratulations to 200th CCPhD student Narelle Keating
Last month the 200th student - Narelle Keating enrolled in the program, signifying a major milestone in networking and information sharing among emerging cancer researchers.
New program to explore opportunities and collaborations
On Thursday 25 October, the Building Capability in Clinical Trials Program was kick-started at the Parkville Integrated Palliative Care Service.
As I was preparing to attend the World Cancer Congress last week I was struck by the authenticity and relevance of a speech happening at another world forum.
As Australia’s only fully-fledged comprehensive cancer centre, our distributed leadership model is essential to a community that crosses institutional, organisation and expertise boundaries.
New Immunotherapy Centre A Game Changer for Victorian Cancer Patients
The centre will mean more Victorian cancer patients will be able to take part in potentially life-saving immunotherapy-based clinical trials and treatments.
Dr Anna Boltong appointed Associate Director of the Victorian Comprehensive Cancer Centre alliance
As the VCCC alliance accelerates efforts to deliver its $30 million Strategic Research Plan by 2020, we are delighted to announce the appointment of Dr Anna Boltong to the key leadership position of Associate Director. This is a pivotal role providing strategic and operational oversight across the VCCC’s main portfolio areas, with particular focus on program quality and long-term sustainability.